Infusible platelet membranes improve hemostasis in thrombocytopenic blood: Experimental studies under flow conditions

Transfusion

Volumn 40, Issue 9, 2000, Pages 1074-1080

  Galán, Ana Maria ^a,b   Bozzo, Jordi ^a   Hernández, Maria Rosa ^a   Pino, Marcos ^a   Reverter, Juan Carlos ^a   Mazzara, Roberto ^a   Escolar, Ginés ^a   Ordinas, Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; THROMBOCYTE CONCENTRATE;

ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BLOOD COMPONENT THERAPY; BLOOD VESSEL INJURY; CELL INTERACTION; DOSE RESPONSE; FIBRIN DEPOSITION; HEMOSTASIS; HUMAN; HUMAN CELL; LEUKOCYTE; MORPHOMETRICS; NONHUMAN; RABBIT; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE MEMBRANE; THROMBOCYTOPENIA;

BLOOD PLATELETS; CELL MEMBRANE; ENDOTHELIUM, VASCULAR; FIBRIN; HEMOSTASIS; HUMANS; PLATELET TRANSFUSION; THROMBOCYTOPENIA;

EID: 0033823078     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40091074.x     Document Type: Article

References (48)

1. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules
2. Platelet procoagulant activity: Physiological significance and mechanims of exposure
3. Biochemistry, physiology, and function of platelets stored as concentrates
4. The cellular and molecular basis of the platelet storage lesion: A symposium summary
5. The storage lesion of platelets: Ultrastructural and functional aspects
6. Mechanisms involved in platelet vessel wall interaction
7. Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions
8. Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: Potential for long-term storage of dried platelets for transfusion
9. Platelet transfusion therapy: Platelet concentrate preparation and storage
10. Novel platelet products and substitutes
11. Infusible platelet membrane microvesicles: A potential transfusion substitute for platelets
12. Frozen ptatelets and platelets substitutes in transfusion medicine
13. A phase I study of safety and efficacy for infusible platelet membrane in patients
14. Infusible platelet membranes (IPM) for control of bleeding in thrombocytopenic patients
15. Effects of storage on platelet reactivity to arterial subendothelium during blood flow
16. Interaction of long-term stored platelets with vascular subendothelium
17. Contribution of perfusion techniques to the evaluation of the hemostatic effectiveness of PCs
18. Platelet microvesicles adhere to subendothelium and promote adhesion of platelets
19. The role of the Baumgartner technique in transfusion medicine: Research and clinical applications
20. Platelet concentrates promote procoagulant activity: Evidence from experimental studies using a perfusion technique
21. In vitro evaluation of the hemostatic effectiveness of non viable platelet preparations: Studies with frozen-thawed, sonicated or lyophilized platelets
22. Preparations of synthetic phospholipids promote procoagulant activity on damaged vessels: Studies under flow conditions
23. Activation of endothelial cells induces platelet thrombus formation on their matrix. Studies of new in vitro thrombosis model with low-molecular-weight heparin as anticoagulant
24. Removal of white cells from red cells by transfusion through a new filter
25. Development of a computer program to analyze the parameters of platelet-vessel wall interaction
26. Platelet interaction with collagen fibrils in flowing blood. I. Reaction of human platelet with α-chymotrypsyin digested subendothelium
27. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi
28. Platelet adhesion
29. Prothrombin fragment 1+2 and thrombin antithrombin complex measurements indicate continuous and progressive intraoperative thrombin generation in liver transplantation
30. Procoagutant effect of incompatible platelet transfusions in alloimmunized refractory patients
31. Pathophysiologic of membrane phospholipid asymmetry in blood cells
32. Transbilayer movement of phospholipids in red cell and platelet membranes
33. Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets
34. Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood
35. Further studies on the presence of functional tissue factor activity on the subendothelium of normal human and rabbit arteries
36. Analysis of the kinetics of factor X activation by tissue factor-factor VIIA
37. Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits
38. Platelet membrane microparticles in blood bank flesh frozen plasma and cryoprecipitate
39. Platelet membrane glycoprotein changes during the preparation and storage of PCs
40. Evaluation of the transfusion effectiveness of various platelet concentrates by means of an in vitro perfusion technique
41. Clinical significance of platelet microparticles in autoimmune thrombocytopenias
42. Scott syndrome: A disorder of platelet coagulant activity
43. Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation
44. Contribution of perfusion techniques to the evaluation of the hemostatic effectiveness of PCs
45. Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects
46. The role of platelet microparticles in hemostasis
47. Agglutination of isolated platelet membranes
48. Assessment of potential thrombogenicity of coagulation factor IX concentrates in an in vitro model of human thrombogenesis